Table of Contents Multiple Sclerosis Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025 1 Industry Overview of Multiple Sclerosis 1.1 Multiple Sclerosis Market Overview 1.1.1 Multiple Sclerosis Product Scope 1.1.2 Market Status and Outlook 1.2 Global Multiple Sclerosis Market Size and Analysis by Regions 1.2.1 North America 1.2.2 Europe 1.2.3 China 1.2.4 Rest of Asia Pacific 1.2.5 Central & South America 1.2.6 Middle East & Africa 1.3 Multiple Sclerosis Market by Type 1.3.1 Injectable agents 1.3.2 Oral agents 1.4 Multiple Sclerosis Market by End Users/Application 1.4.1 Hosptial 1.4.2 Research 2 Global Multiple Sclerosis Competition Analysis by Players 2.1 Multiple Sclerosis Market Size (Value) by Players (2018 and 2019) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future 3 Company (Top Players) Profiles 3.1 Abbvie 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Multiple Sclerosis Revenue (Value) (2014-2019) 3.1.5 Recent Developments 3.2 Acorda Therapeutics 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Multiple Sclerosis Revenue (Value) (2014-2019) 3.2.5 Recent Developments 3.3 Bayer HealthCare 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Multiple Sclerosis Revenue (Value) (2014-2019) 3.3.5 Recent Developments 3.4 Biogen 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Multiple Sclerosis Revenue (Value) (2014-2019) 3.4.5 Recent Developments 3.5 Genzyme (Sanofi) 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Multiple Sclerosis Revenue (Value) (2014-2019) 3.5.5 Recent Developments 3.6 GlaxoSmithKline 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Multiple Sclerosis Revenue (Value) (2014-2019) 3.6.5 Recent Developments 3.7 Merck Serono 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Multiple Sclerosis Revenue (Value) (2014-2019) 3.7.5 Recent Developments 3.8 Novartis 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Multiple Sclerosis Revenue (Value) (2014-2019) 3.8.5 Recent Developments 3.9 Pfizer 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Multiple Sclerosis Revenue (Value) (2014-2019) 3.9.5 Recent Developments 3.10 Teva 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Multiple Sclerosis Revenue (Value) (2014-2019) 3.10.5 Recent Developments 4 Global Multiple Sclerosis Market Size by Type and Application (2014-2019) 4.1 Global Multiple Sclerosis Market Size by Type (2014-2019) 4.2 Global Multiple Sclerosis Market Size by Application (2014-2019) 4.3 Potential Application of Multiple Sclerosis in Future 4.4 Top Consumer/End Users of Multiple Sclerosis 5 North America Multiple Sclerosis Development Status and Outlook 5.1 North America Multiple Sclerosis Market Size (2014-2019) 5.2 North America Multiple Sclerosis Market Size and Market Share by Players (2018 and 2019) 6 Europe Multiple Sclerosis Development Status and Outlook 6.1 Europe Multiple Sclerosis Market Size (2014-2019) 6.2 Europe Multiple Sclerosis Market Size and Market Share by Players (2018 and 2019) 7 China Multiple Sclerosis Development Status and Outlook 7.1 China Multiple Sclerosis Market Size (2014-2019) 7.2 China Multiple Sclerosis Market Size and Market Share by Players (2018 and 2019) 8 Rest of Asia Pacific Multiple Sclerosis Development Status and Outlook 8.1 Rest of Asia Pacific Multiple Sclerosis Market Size (2014-2019) 8.2 Rest of Asia Pacific Multiple Sclerosis Market Size and Market Share by Players (2018 and 2019) 9 Central & South America Multiple Sclerosis Development Status and Outlook 9.1 Central & South America Multiple Sclerosis Market Size (2014-2019) 9.2 Central & South America Multiple Sclerosis Market Size and Market Share by Players (2018 and 2019) 10 Middle East & Africa Multiple Sclerosis Development Status and Outlook 10.1 Middle East & Africa Multiple Sclerosis Market Size (2014-2019) 10.2 Middle East & Africa Multiple Sclerosis Market Size and Market Share by Players (2018 and 2019) 11 Market Forecast by Regions, Type and Application (2019-2025) 11.1 Global Multiple Sclerosis Market Size (Value) by Regions (2019-2025) 11.1.1 North America Multiple Sclerosis Revenue and Growth Rate (2019-2025) 11.1.2 Europe Multiple Sclerosis Revenue and Growth Rate (2019-2025) 11.1.3 China Multiple Sclerosis Revenue and Growth Rate (2019-2025) 11.1.4 Rest of Asia Pacific Multiple Sclerosis Revenue and Growth Rate (2019-2025) 11.1.5 Central & South America Multiple Sclerosis Revenue and Growth Rate (2019-2025) 11.1.6 Middle East & Africa Multiple Sclerosis Revenue and Growth Rate (2019-2025) 11.2 Global Multiple Sclerosis Market Size (Value) by Type (2019-2025) 11.3 Global Multiple Sclerosis Market Size by Application (2019-2025) 12 Multiple Sclerosis Market Dynamics 12.1 Multiple Sclerosis Market Opportunities 12.2 Multiple Sclerosis Challenge and Risk 12.2.1 Competition from Opponents 12.2.2 Downside Risks of Economy 12.3 Multiple Sclerosis Market Constraints and Threat 12.3.1 Threat from Substitute 12.3.2 Government Policy 12.3.3 Technology Risks 12.4 Multiple Sclerosis Market Driving Force 12.4.1 Growing Demand from Emerging Markets 12.4.2 Potential Application 13 Market Effect Factors Analysis 13.1 Technology Progress/Risk 13.1.1 Substitutes 13.1.2 Technology Progress in Related Industry 13.2 Consumer Needs Trend/Customer Preference 13.3 External Environmental Change 13.3.1 Economic Fluctuations 13.3.2 Other Risk Factors 14 Research Finding/Conclusion 15 Appendix Methodology Analyst Introduction Data Source

List of Tables and Figures Figure Multiple Sclerosis Product Scope Figure Global Multiple Sclerosis Market Size (Million USD) (2014-2019) Table Global Multiple Sclerosis Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Global Multiple Sclerosis Market Share by Regions in 2018 Figure North America Multiple Sclerosis Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Europe Multiple Sclerosis Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure China Multiple Sclerosis Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Rest of Asia Pacific Multiple Sclerosis Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Central & South America Multiple Sclerosis Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Middle East & Africa Multiple Sclerosis Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Global Multiple Sclerosis Market Share by Type in 2018 Figure Injectable agents Market Size (Million USD) and Growth Rate (2014-2019) Figure Oral agents Market Size (Million USD) and Growth Rate (2014-2019) Figure Global Multiple Sclerosis Market Share by Application in 2018 Table Key Downstream Customer in Hosptial Figure Multiple Sclerosis Market Size (Million USD) and Growth Rate in Hosptial (2014-2019) Table Key Downstream Customer in Research Figure Multiple Sclerosis Market Size (Million USD) and Growth Rate in Research (2014-2019) Table Multiple Sclerosis Market Size (Million USD) by Players (2018 and 2019) Figure Multiple Sclerosis Market Size Share by Players in 2018 Figure Multiple Sclerosis Market Size Share by Players in 2019 Table Abbvie Basic Information List Table Multiple Sclerosis Business Revenue (Million USD) of Abbvie (2014-2019) Figure Abbvie Multiple Sclerosis Business Revenue Market Share in 2018 Table Acorda Therapeutics Basic Information List Table Multiple Sclerosis Business Revenue (Million USD) of Acorda Therapeutics (2014-2019) Figure Acorda Therapeutics Multiple Sclerosis Business Revenue Market Share in 2018 Table Bayer HealthCare Basic Information List Table Multiple Sclerosis Business Revenue (Million USD) of Bayer HealthCare (2014-2019) Figure Bayer HealthCare Multiple Sclerosis Business Revenue Market Share in 2018 Table Biogen Basic Information List Table Multiple Sclerosis Business Revenue (Million USD) of Biogen (2014-2019) Figure Biogen Multiple Sclerosis Business Revenue Market Share in 2018 Table Genzyme (Sanofi) Basic Information List Table Multiple Sclerosis Business Revenue (Million USD) of Genzyme (Sanofi) (2014-2019) Figure Genzyme (Sanofi) Multiple Sclerosis Business Revenue Market Share in 2018 Table GlaxoSmithKline Basic Information List Table Multiple Sclerosis Business Revenue (Million USD) of GlaxoSmithKline (2014-2019) Figure GlaxoSmithKline Multiple Sclerosis Business Revenue Market Share in 2018 Table Merck Serono Basic Information List Table Multiple Sclerosis Business Revenue (Million USD) of Merck Serono (2014-2019) Figure Merck Serono Multiple Sclerosis Business Revenue Market Share in 2018 Table Novartis Basic Information List Table Multiple Sclerosis Business Revenue (Million USD) of Novartis (2014-2019) Figure Novartis Multiple Sclerosis Business Revenue Market Share in 2018 Table Pfizer Basic Information List Table Multiple Sclerosis Business Revenue (Million USD) of Pfizer (2014-2019) Figure Pfizer Multiple Sclerosis Business Revenue Market Share in 20187 Table Teva Basic Information List Table Multiple Sclerosis Business Revenue (Million USD) of Teva (2014-2019) Figure Teva Multiple Sclerosis Business Revenue Market Share in 2018 Table Global Multiple Sclerosis Market Size (Million USD) by Type (2014-2019) Figure Global Multiple Sclerosis Market Size Share by Type in 2014 Figure Global Multiple Sclerosis Market Size Share by Type in 2015 Figure Global Multiple Sclerosis Market Size Share by Type in 2016 Figure Global Multiple Sclerosis Market Size Share by Type in 2017 Figure Global Multiple Sclerosis Market Size Share by Type in 2018 Figure Global Multiple Sclerosis Market Size Share by Type in 2019 Table Global Multiple Sclerosis Market Size (Million USD) by Application (2014-2019) Figure Global Multiple Sclerosis Market Size (Million USD) by Application in 2014 Figure Global Multiple Sclerosis Market Size (Million USD) by Application in 2015 Figure Global Multiple Sclerosis Market Size (Million USD) by Application in 2015 Figure Global Multiple Sclerosis Market Size (Million USD) by Application in 2017 Figure Global Multiple Sclerosis Market Size (Million USD) by Application in 2018 Figure Global Multiple Sclerosis Market Size (Million USD) by Application in 2019 Table Top Consumer/End Users of Multiple Sclerosis Figure North America Multiple Sclerosis Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table North America Multiple Sclerosis Market Size (Million USD) by Players (2014-2019) Figure North America Multiple Sclerosis Market Size Share by Players in 2018 Figure North America Multiple Sclerosis Market Size Share by Players in 2019 Figure Europe Multiple Sclerosis Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Europe Multiple Sclerosis Market Size (Million USD) by Players (2014-2019) Figure Europe Multiple Sclerosis Market Size Share by Players in 2018 Figure Europe Multiple Sclerosis Market Size Share by Players in 2019 Figure China Multiple Sclerosis Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table China Multiple Sclerosis Market Size (Million USD) by Players (2014-2019) Figure China Multiple Sclerosis Market Size Share by Players in 2018 Figure China Multiple Sclerosis Market Size Share by Players in 2019 Figure Rest of Asia Pacific Multiple Sclerosis Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Rest of Asia Pacific Multiple Sclerosis Market Size (Million USD) by Players (2014-2019) Figure Rest of Asia Pacific Multiple Sclerosis Market Size Share by Players in 2018 Figure Rest of Asia Pacific Multiple Sclerosis Market Size Share by Players in 2019 Figure Central & South America Multiple Sclerosis Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Central & South America Multiple Sclerosis Market Size (Million USD) by Players (2014-2019) Figure Central & South America Multiple Sclerosis Market Size Share by Players in 2018 Figure Central & South America Multiple Sclerosis Market Size Share by Players in 2019 Figure Middle East & Africa Multiple Sclerosis Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Middle East & Africa Multiple Sclerosis Market Size (Million USD) by Players (2014-2019) Figure Middle East & Africa Multiple Sclerosis Market Size Share by Players in 2018 Figure Middle East & Africa Multiple Sclerosis Market Size Share by Players in 2019 Figure Global Multiple Sclerosis Market Size (Million USD) by Regions (2019-2025) Table Global Multiple Sclerosis Market Size (Million USD) by Regions (2019-2025) Figure Global Multiple Sclerosis Market Size Share by Regions in 2019 Figure Global Multiple Sclerosis Market Size Share by Regions in 2025 Figure North America Multiple Sclerosis Revenue (Million USD) and Growth Rate (2019-2025) Figure Europe Multiple Sclerosis Revenue (Million USD) and Growth Rate (2019-2025) Figure China Multiple Sclerosis Revenue (Million USD) and Growth Rate (2019-2025) Figure Rest of Asia Pacific Multiple Sclerosis Revenue (Million USD) and Growth Rate (2019-2025) Figure Central & South America Multiple Sclerosis Revenue (Million USD) and Growth Rate (2019-2025) Figure Middle East & Africa Multiple Sclerosis Revenue (Million USD) and Growth Rate (2019-2025) Table Global Multiple Sclerosis Market Size (Million USD) by Type (2019-2025) Figure Global Multiple Sclerosis Market Size Share by Type in 2019 Figure Global Multiple Sclerosis Market Size Share by Type in 2025 Table Global Multiple Sclerosis Market Size (Million USD) by Application (2019-2025) Figure Global Multiple Sclerosis Market Size (Million USD) by Application in 2019 Figure Global Multiple Sclerosis Market Size (Million USD) by Application in 2025

Abbvie Acorda Therapeutics Bayer HealthCare Biogen Genzyme (Sanofi) GlaxoSmithKline Merck Serono Novartis Pfizer Teva